Industry: Pharmaceuticals, Biotechnology
Cambria Biosciences is an innovative biotechnology company that combines the power of genetics, physiological disease models and high-throughput chemical screening to discover new drug leads and how they work. Cambria’s scientists characterize the mechanism of action of each promising biologically active compound in conjunction with secondary screens, with a current focus on neurodegenerative diseases, infectious disease pests, and drug rescue. With this platform, the Company will develop new therapeutic candidates with enhanced likelihood of clinical success to address unmet medical needs. Cambria Biosciences earns revenues from partnerships that leverage its technology platform for multiple applications. The company began operations in 1999 and is based in the Greater Boston area. ( www.cambriabio.com )
Cambria Biosciences LLC
8A Henshaw St.
Woburn, Massachusetts 01801
USA
Tel: (781) 938-1333